Advertisement
Home »

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.

Jan 29, 2024

ABOUT THE EXPERTS

  • Yoon-Koo Kang

    Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea. ykkang@amc.seoul.kr.

    Min-Hee Ryu

    Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.

    Maria Di Bartolomeo

    Fondazione IRCCS-Istituto Nazionale Tumori, Milan, Italy.

    Ian Chau

    Royal Marsden Hospital, Sutton, UK.

    Harry Yoon

    Mayo Clinical Cancer Center, Rochester, MN, USA.

    Jong Gwang Kim

    Kyungpook National University Chilgok Hospital, Daegu, Gyeonggi-Do, Korea.

    Keun-Wook Lee

    Seoul National University College of Medicine, Seoul National University Bundang Hospital, Songnam, Korea.

    Sang Chul Oh

    Korea University Guro Hospital, Seoul, Korea.

    Atsuo Takashima

    National Cancer Center Hospital, Tokyo, Japan.

    Anna Kryzhanivska

    Ivano-Frankivsk Regional Oncological Center, Ivano-Frankivsk, Ukraine.

    Yee Chao

    Taipei Veterans General Hospital, Taipei, Taiwan.

    Ludovic Evesque

    Centre Antoine-Lacassagne, Nice, France.

    Michael Schenker

    Centrul de Oncologie ‘Sf. Nectarie’, Sectia de Oncologie Medicala, Craiova, Romania.

    Arlo McGinn

    Elevar Therapeutics, Inc, Fort Lee, NJ, USA.

    Yufan Zhao

    Elevar Therapeutics, Inc, Fort Lee, NJ, USA.

    Jennifer Lee

    Elevar Therapeutics, Inc, Fort Lee, NJ, USA.

    Lucjan Wyrwicz

    Klinika Onkologii I Radioterapii, Centrum Onkologii, Instytut Im.Marii Sklodowskiej-Curie, Warsaw, Poland.

    Narikazu Boku

    National Cancer Center Hospital, Tokyo, Japan.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement